Back to results
US 9,540,335 B2Granted
Salts of an epidermal growth factor receptor kinase inhibitor
AssigneeCelgene Avilomics Research, Inc.
InventorsMei Lai, Steven Richard Witowski, Richland Wayne Tester, Kwangho Lee
Life of this patent
Estimating the term…
Abstract
The present invention provides a salt form and compositions thereof, which are useful as an inhibitor of EGFR kinases and which exhibits desirable characteristics for the same.
Claims20
Compound 2:
- wherein:
- n is 1 or 2;
- and
- X is hydrobromic acid, benzenesulfonic acid, camphor sulfonic acid, 1,2-ethane disulfonic acid, hydrochloric acid, maleic acid, methanesulfonic acid, naphthalene-2-sulfonic acid, 1,5-naphthalene disulfonic acid, oxalic acid, 4-toluenesulfonic acid or 2,4,6-trihydroxybenzoic acid.
1 more element
Dependencies are inferred from the claim text.